Isolated limb perfusion with high-dose tumor necrosis factor-alpha for locally advanced extremity soft tissue sarcomas.

Cancer treatment and research

Volumn 91, Issue , 1997, Pages 189-203

  Eggermont, A M ^a   Schraffordt Koops, H ^a   Klausner, J M ^a   Schlag, P M ^a   Kroon, B B ^a   Ben Ari, G ^a   Lejeune, F J ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL TRIAL; DOSE RESPONSE; DRUG ADMINISTRATION; FEMALE; HUMAN; LIMB; MALE; MIDDLE AGED; MORTALITY; REGIONAL PERFUSION; SARCOMA; SOFT TISSUE TUMOR; SURVIVAL RATE; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHEMOTHERAPY, CANCER, REGIONAL PERFUSION; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; EXTREMITIES; FEMALE; HUMANS; MALE; MIDDLE AGED; SARCOMA; SOFT TISSUE NEOPLASMS; SURVIVAL RATE; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA;

MLCS; MLOWN;

EID: 0030625628     PISSN: 09273042     EISSN: None     Source Type: Journal    
DOI: 10.1007/978-1-4615-6121-7_13     Document Type: Article

References (0)